Redmile Group as of June 30, 2022
Portfolio Holdings for Redmile Group
Redmile Group holds 71 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fate Therapeutics (FATE) | 12.3 | $321M | 13M | 24.78 | |
Amicus Therapeutics (FOLD) | 9.1 | $238M | 22M | 10.74 | |
Seagen | 5.8 | $151M | 854k | 176.94 | |
Argenx Se Sponsored Adr (ARGX) | 5.6 | $146M | 386k | 378.88 | |
Krystal Biotech (KRYS) | 4.8 | $125M | 1.9M | 65.66 | |
Livanova SHS (LIVN) | 3.9 | $101M | 1.6M | 62.47 | |
Horizon Therapeutics Pub L SHS | 2.8 | $73M | 913k | 79.76 | |
Beam Therapeutics (BEAM) | 2.7 | $72M | 1.8M | 38.71 | |
The Beauty Health Company Com Cl A (SKIN) | 2.5 | $67M | 5.2M | 12.86 | |
Replimune Group (REPL) | 2.4 | $64M | 3.6M | 17.48 | |
Igm Biosciences (IGMS) | 2.3 | $60M | 3.3M | 18.03 | |
Adc Therapeutics Sa SHS (ADCT) | 2.3 | $60M | 7.5M | 7.95 | |
Celldex Therapeutics Com New (CLDX) | 2.1 | $56M | 2.1M | 26.96 | |
Centene Corporation (CNC) | 2.1 | $55M | 651k | 84.61 | |
Kymera Therapeutics (KYMR) | 2.0 | $51M | 2.6M | 19.69 | |
Xenon Pharmaceuticals (XENE) | 1.9 | $50M | 1.6M | 30.42 | |
Regenxbio Inc equity us cm (RGNX) | 1.9 | $50M | 2.0M | 24.70 | |
Atara Biotherapeutics (ATRA) | 1.9 | $49M | 6.2M | 7.79 | |
ImmunoGen | 1.6 | $41M | 9.1M | 4.50 | |
Anthem (ELV) | 1.5 | $41M | 84k | 482.57 | |
Science 37 Holdings | 1.5 | $40M | 20M | 2.01 | |
Medavail Holdings Ord | 1.5 | $39M | 25M | 1.53 | |
Nurix Therapeutics (NRIX) | 1.5 | $38M | 3.0M | 12.67 | |
Repare Therapeutics Ord (RPTX) | 1.5 | $38M | 2.7M | 13.99 | |
1life Healthcare | 1.4 | $36M | 4.5M | 7.84 | |
Verve Therapeutics (VERV) | 1.1 | $28M | 1.8M | 15.28 | |
Absci Corp (ABSI) | 1.0 | $27M | 8.0M | 3.32 | |
Stoke Therapeutics (STOK) | 1.0 | $26M | 2.0M | 13.21 | |
Augmedix (AUGX) | 1.0 | $26M | 14M | 1.80 | |
BioMarin Pharmaceutical (BMRN) | 0.9 | $25M | 300k | 82.87 | |
Pliant Therapeutics (PLRX) | 0.9 | $25M | 3.1M | 8.01 | |
Entrada Therapeutics (TRDA) | 0.9 | $24M | 2.0M | 12.18 | |
Shattuck Labs (STTK) | 0.9 | $23M | 5.6M | 4.06 | |
Oak Street Health | 0.9 | $23M | 1.4M | 16.44 | |
Zymeworks | 0.8 | $20M | 3.8M | 5.30 | |
Prothena Corp SHS (PRTA) | 0.8 | $20M | 736k | 27.15 | |
Deciphera Pharmaceuticals (DCPH) | 0.7 | $19M | 1.4M | 13.15 | |
Scholar Rock Hldg Corp (SRRK) | 0.7 | $19M | 3.4M | 5.49 | |
Nevro (NVRO) | 0.7 | $18M | 406k | 43.83 | |
Stevanato Group S P A Ord Shs (STVN) | 0.7 | $18M | 1.1M | 15.81 | |
Gritstone Oncology Ord (GRTS) | 0.6 | $17M | 7.0M | 2.42 | |
Akero Therapeutics (AKRO) | 0.6 | $15M | 1.6M | 9.45 | |
Rapt Therapeutics (RAPT) | 0.6 | $15M | 818k | 18.25 | |
Iveric Bio | 0.6 | $15M | 1.5M | 9.62 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.6 | $15M | 93k | 156.01 | |
Annexon (ANNX) | 0.5 | $13M | 3.5M | 3.77 | |
Nuvation Bio Com Cl A (NUVB) | 0.4 | $11M | 3.5M | 3.24 | |
Tandem Diabetes Care Com New (TNDM) | 0.4 | $11M | 188k | 59.19 | |
Somalogic Class A Com | 0.4 | $9.4M | 2.1M | 4.52 | |
Invitae (NVTAQ) | 0.4 | $9.3M | 3.8M | 2.44 | |
Bioventus Com Cl A (BVS) | 0.3 | $8.9M | 1.3M | 6.82 | |
Oncology Institu (TOI) | 0.3 | $8.8M | 1.7M | 5.06 | |
Lava Therapeutics Nv SHS (LVTX) | 0.3 | $8.1M | 2.8M | 2.86 | |
Allakos (ALLK) | 0.3 | $8.0M | 2.5M | 3.13 | |
Hookipa Pharma Inc equity (HOOK) | 0.3 | $7.4M | 4.6M | 1.63 | |
Adagio Therapeutics (IVVD) | 0.2 | $6.3M | 1.9M | 3.28 | |
Alx Oncology Hldgs (ALXO) | 0.2 | $6.2M | 767k | 8.09 | |
Privia Health Group (PRVA) | 0.2 | $6.0M | 206k | 29.12 | |
Alpha Teknova (TKNO) | 0.2 | $4.8M | 568k | 8.40 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.2 | $4.1M | 1.6M | 2.52 | |
Immatics SHS (IMTX) | 0.1 | $3.9M | 450k | 8.71 | |
Neoleukin Therapeutics | 0.1 | $3.5M | 3.4M | 1.03 | |
Allovir (ALVR) | 0.1 | $3.2M | 823k | 3.90 | |
Tcr2 Therapeutics Inc cs | 0.1 | $3.2M | 1.1M | 2.90 | |
Stereotaxis Com New (STXS) | 0.1 | $2.7M | 1.5M | 1.84 | |
Xeris Pharmaceuticals (XERS) | 0.1 | $1.6M | 1.0M | 1.54 | |
Atreca Cl A Com (BCEL) | 0.1 | $1.4M | 800k | 1.79 | |
Sonendo (SONX) | 0.0 | $857k | 498k | 1.72 | |
Cabaletta Bio (CABA) | 0.0 | $738k | 696k | 1.06 | |
Cytosorbents Corp Com New (CTSO) | 0.0 | $583k | 266k | 2.19 | |
Ayala Pharmaceuticals Incorporated | 0.0 | $372k | 341k | 1.09 |